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Abstract 
Background: Emerging evidence suggests that by affecting mineral balance, aluminum (Al) 
may enhance some events associated with neurodegenerative diseases. Aim: To examine the 
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effect of Al(NO3)3 exposure on brain Al, cooper (Cu), iron (Fe), magnesium (Mg), 
manganese (Mn), silicon (Si), and zinc (Zn) levels, and the metal-change implication in brain 
oxidant and inflammatory status. Methods: Four groups of six-week-old male NMRI mice 
were treated for three months: i) controls, administrated with deionized water; ii) Al, which 
received Al(NO3)3; iii) Al+silicic acid, which were given Al(NO3)3 plus silicic acid; and iv) 
Al+beer, which received Al(NO3)3 plus beer. Results: Brain Al and TBARS levels and TNFα 
and GPx expressions increased, while Cu, Mn, and Zn levels, and catalase and CuZn-SOD 
expression decreased (at least, p < 0.05) in Al versus control animals. Al, Si, and TBARS 
levels and TNFα expression decreased (p < 0.05) in Al+silicic acid and Al+beer specimens 
while Cu, Mn, and Zn levels and antioxidant expression increased versus the Al group. Brain 
Al levels correlated negatively with those of Cu, Fe, Mn, and Zn, and catalase, CuZn-SOD, 
and GPx enzyme expressions but positively with Si and TBARS levels and TNFα expression. 
Two components of the principal component analysis (PCA) explained 71.2% of total data 
variance (p < 0.001). PCA connected the pro-oxidant markers with brain Al content, while 
brain Zn and Cu levels were closer to antioxidant enzyme expression. Conclusion: 
Administration of Al(NO3)3 induced metal imbalance, inflammation, and antioxidant status 
impairment in the brain. Those effects were blocked to a significant extent by silicic acid and 
beer administration.  
Keywords: Aluminum, Beer, Silicic acid, Metals, Antioxidants, Enzyme expressions, TNF, 
TBARS, Brain.   
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Abbreviations 
AD, Alzheimer disease; CAT, catalase; GPX, glutathione peroxidase; SOD, superoxide 
dismutase; PCA, Principal component analysis; TBARS, thiobarbituric acid-reactive 
substances; TNFα, tumor necrotic factor. 
Introduction 
Metal dyshomeostasis, especially for endogenous metal ions such as copper (Cu), iron 
(Fe), manganese (Mn), zinc (Zn) or the exogenous contaminant aluminum (Al), has attracted 
recent interest on the etiology of a variety of neurodegenerative conditions [1]. Maintaining 
transition metal homeostasis is known to be important in a wide variety of biological 
functions, such as anti-oxidant defense mechanisms. However how metals, such as Al, Cu, Fe 
and Mn, contribute to oxidative stress and protein aggregation leading to neurodegenerative 
diseases remains unclear [2]. Among several possible mechanisms, the promotion of α-
synuclein aggregation and fibril formation, the activation of microglial cells leading to 
inflammation and impaired production of metalloproteins have been proposed [2]. It has been 
suggested that Al may be involved in the formation of neurofibrillary tangles in the brain [3]. 
An unusual aspect of the biochemistry of this non-redox active metal is its pro-oxidant 
activity, which might be explained by the formation of an Al superoxide semireduced radical 
ion AlO2
.2+
 [3]. 
Yang et al.,[4] found that Fe, Zn, Mn, and Cu concentrations were significantly 
decreased in serum after administrating Al to rats, possibly because Al load caused an 
increase in the transport of Fe, Mn, Cu, and Zn into liver cells. There is evidence that the 
exposure to Al causes an increase in both oxidative stress and inflammatory events [5]. 
Furthermore, this neurotoxic metal can modify the levels of other metals in the brain, and this 
phenomenon has been suggested to be part of its mechanism of action [6].  
Silicon (Si) has recently been recognized to exert health benefits with regard to skeletal 
and neurological function and status [7]. Very recently our group found that organic Si 
protected neuroblastoma cells from H2O2 aggression [8, 9] and improved the antioxidant 
status of aged rats fed cholesterol-enriched diets [10]. Although action mechanisms are not- 
well known, it has been proposed that Si among others may decrease Al bioavailability by 
blocking its uptake through the gastrointestinal tract [11] and by impeding reabsorption [12]. 
Bioavailable Si, that is, Si in the form of silicic acid or orthosilicic acid, is mainly found in 
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foods rich in fiber and whole grains [13], with beer being one of the main sources of this 
element. Si in beer is present chiefly in a monomeric form [14]. A previous paper [15] 
demonstrated that beer intake affects the kinetics of Al uptake and excretion, possibly due to 
an interaction between Al and Si in the digestive tract. Therefore, Si in the form of silicic acid 
may lower Al bioavailability, and hence should be considered an element that may protect 
against Al toxicity in the brain. In addition, our group has also demonstrated that the ingestion 
of Si as silicic acid or beer prevented lipid oxidation and pro-inflammatory effects induced by 
Al exposition [5] reverting the decline of mRNA expression of several endogenous 
antioxidant enzymes. Thus, keeping in mind all these results present paper hypothesized that 
Al administration negatively affects brain level of various metals, some of them involved in 
antioxidant/pro-oxidant reactions; thus, causing oxidative stress and inflammatory deleterious 
effects. In addition, the simultaneous incorporation of Al and Si, as silicic acid or beer, arrests 
those negative effects. 
The aims of the present study were to (1) evaluate the relationship between levels of Al 
and other transition metals (i.e., Cu, Fe, Mg, Mn, Si and Zn) in the mouse brain, (2) establish 
correlations between metal levels obtained and gene expression of certain antioxidant 
enzymes, and (3) attempt to elucidate other possible mechanisms of Al induced toxicity. 
 
Material and methods 
Reagents 
Al nitrate [Al(NO3)3 .9H2O] (Aldrich, CAS 7784-27-2) and silicic acid,  Si(OH)4 (Fluka 
Chemie, Buchs, Switzerland) were used. Silicic acid was dissolved in 0.9% saline solution 
and 2% ethanol. Al nitrate was dissolved in 0.9% saline. Both chemicals were orally 
administered at a volume of 0.5 ml. 
Animals and treatments 
Six-week-old male NMRI mice (weighing approximately 30 g) were obtained from the 
Animal Research Center, University of Alcalá, homologated by the Spanish Competent 
Authority, Register Number ES280050001165 implementing the Spanish Royal Decree 
53/2013 and the European Directive 63/2010/EU. The protocol employed in this experiment 
was approved by the Ethics Committee of the Universidad de Alcalá (Spain). All procedures 
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were performed in compliance with the Directive 63/2010/EU, for the protection of animals in 
research. 
The animals were randomly divided into four groups (n = 12 per group). A control 
group (Group 1), receiving only deionized water, was used as the negative control. The three 
treatment groups were exposed for three months to aluminum nitrate, Al(NO3)3·9H2O, at 450 
μg/ml via drinking water. The solutions were prepared daily and the content of Al was 
measured in each batch. This methodology for long-term exposure of mice to Al is based on 
previous studies from our lab [15] and others [16]. Group 2 received only Al nitrate (Al group 
or positive control); Group 3 (Al+Si group) received Al nitrate and a solution of silicic acid 
(Si(OH)4) at a concentration of 50 mg/ml; and finally group 4 (Al+beer group) was given the 
same dose of Al nitrate and an amount of commercial beer (5.5% alcohol by volume) 
equivalent to moderate to high consumption in humans (1 l/day). A previous study [17], 
demonstrated that the same doses of alcoholic beer were more effective than non-alcoholic 
beer. According to [15], the Si concentration in the tested beer was 24.56 ± 2.45μg/g while 
that of Al 0.40 ± 0.12 μg/g. All animals were weighed weekly. The mice were housed in an 
animal room under standard conditions of temperature (21 ± 1º C) and humidity (55 ± 10%), 
with a 12-h light/12-h dark cycle. 
At the end of the treatment period, animals were euthanized after anesthesia with 
isofluorane by heart puncture and total and terminal bleeding, and brain tissue samples were 
taken for subsequent analysis. The right hemibrain was used to determine mineral content, 
while the left hemibrain was washed with saline solution, minced and homogenized (10%, 
w/v) separately in ice-cold 1.15% KCl–0.01M sodium, potassium phosphate buffer (pH 7.4) 
in a Potter–Elvehjem type homogenizer. The homogenate was centrifuged at 10,000g for 20 
min at 4 
o
C, and the resultant supernatant was used for biochemical analysis. 
Analytical methods 
The mineral levels in the brain were measured after ashing of the organic matter according to 
the method proposed by Granero et al., 2004 [18]. Each sample (2.5 ml) was digested with 2 
ml of 65% nitric acid (Suprapur, Merck, Darmstad, Germany) in Teflon bombs for 8 h at 
room temperature, and subsequently heated at 100 º C for 12 h. After cooling, solutions were 
filtered and made up to 25 ml with deionized water. 
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Si content of the brain was measured by means of inductively coupled plasma atomic 
emission spectrometry ICP-OES (Perkin Elmer Optima model 3200 RL), using Si emission 
lines of 254.611 nm and 212.412 nm. Brain levels of Al were determined by means of 
inductively coupled plasma mass spectrometry (Perkin Elmer Elan model 6000, ICP-MS), 
using the only Al isotope, Al27. The emission lines and isotopes used are free of spectral 
interferences in these matrix types. Multi-element analysis of Mn in digested samples was 
performed with ICP-MS spectrometry, while the other elements (Cu, Mg, Fe, Zn) were 
analyzed with ICP-OES spectrometry. Elements with the highest isotopic abundance, free 
from isobaric and polyatomic interferences, were selected as analytical mass to perform 
determinations by ICP-MS spectrometry. When ICP-OES spectrometry was employed, 
possible interferences and selection of analytical lines were checked selecting three of the 
most sensitive spectral lines.  
Validation of the methods, based on the ICP-OES and ICP-MS techniques, was 
performed according to EURACHEM guidelines, 1998 [19] with regard to accuracy, 
precision, sensitivity, and linearity, using the experimental setting that provided the optimal 
conditions. According to these guidelines, intra-assay and inter-assay imprecision, measured 
as variation coefficients, should be below 5 and 10% respectively. Sensitivity of the 
determination of each chemical element was expressed by the slope of the linear regression 
equation. Linearity was assessed by the correlation coefficients of calibration curves and was 
considered acceptable when r ≥ 0.9995. Detection limits were calculated on the basis of the 3s 
criterion for ten replicate measurements of blank solutions subjected to the same treatment as 
the samples. 
The accuracy of the instrumental methods was validated by replicating all samples and 
by taking measurements of reference material (lobster hepatopancreas, NRC Canada TORT 2) 
every 10 samples. Quantification was based on the most abundant isotope of each element 
free of analytical interferences. The mean recovery rates were between 90% and 95%. 
Biochemical assays 
Using an Uvikon 930 spectrophotometer, lipid peroxidation was measured by following the 
formation of malonaldehyde (MDA), according to the presence of thiobarbituric acid reactive 
substances (TBARS) in the brain homogenates [20]. Concentrations were calculated using a 
standard curve obtained with MDA. TBARS values were expressed as μmols of MDA per mg 
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protein. Protein was determined by the Bradford method [21], with bovine serum albumin as 
the standard.  
RT-PCR real time analysis 
Total RNA was extracted from frozen brain samples following the guanidinium 
thiocyanate/phenol reagent method [22]. Reverse transcription and amplification using the 
Titan system involved the preparation of a master-mix 1 and 2 on ice. Mix 1 was comprised 
of dNTPs, primers, dithiothreitol (DTT), extracted RNA (1 μg) and sterile pre-chilled 
deionized water. Mix 2 consisted of RT-PCR buffer, enzyme mix (AMV reverse 
transcriptase, Taq DNA polymerase) and sterile pre-chilled deionized water. All reagents 
were thawed, vortexed briefly and centrifuged before setting up the reactions. Twenty-five 
microliters each of master mix 1 and 2 was added to a 0.2 ml PCR tubes kept on ice. This was 
vortexed and centrifuged briefly to collect the sample at the bottom of the tube, and RT was 
carried out at 50 oC for 30 min. β-actin cDNA was used as an internal control. 
The sequences of the primers were as follows: 
SOD sense: 50-GCCGTGTGCGTGCTGAA-30; 
SOD antisense: 50-TTTCCACCTTTGCCCAAGTCA-30; 
b-Actin sense: 50-TACAACCTCCTTGCAGCTCC-30; 
b-Actin antisense: 50-GGATCTTCATGAGGTAGTCAGTC-30. 
The number of PCR cycles was adjusted to avoid saturation of the amplification system: 95º 
for 30 s, 5º for 1 min and 72º for 30 s (30 cycles) for SOD; 58º for 45 s and 72º for 30 s (24 
cycles) for b-actin with a final elongation at 72º for 10 min. Amplification products were 
visualized on 1.8% agarose gels containing ethidium bromide (1 μg/ml): SOD product, 383 
bp; b-actin product 630 bp. A 100 bp DNA ladder was used as marker. The products were 
quantified by laser densitometry. 
Principal component analysis 
PCA test was applied to understand possible associations between some of the mineral 
determined and the pro- and antioxidants parameters analyzed. Ten different variables were 
tested, five, related to mineral content (Zn, Cu, Mn, Si, and Al), and five about antioxidant 
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markers (CuZnSOD, Catalase, GPx, TNF-alpha and TBARs). PCA create new variables 
(principal components (PCs)) containing the initial variables which correlate among them. 
Statistical analysis 
All analyses were performed in triplicate. Data were expressed as means ± SD. The Kruskal–
Wallis non-parametric test followed by multiple non-parametric comparison test [23] were 
used. Spearman correlations were performed to study the relationship between minerals and 
TBARS, TNFα and the different expressions antioxidant enzymes. P values of <0.05 were 
considered statistically significant. Statistical analyses were performed using the SPSS 
statistical software package (version 15.0) and the SAS (version 19.0). 
Results 
Brain tissue Al and trace metals levels 
Table 1 presents the concentrations of Al, Cu, Fe, Mg, Mn and Zn in mouse brain from the 
different treatment groups. Al exposition significantly increased brain Al and Si contents but 
significantly decreased (p <0.05) Cu, Mn and Zn levels. In presence of Al exposition, beer or 
silicic acid, significantly lowered Al and Si levels and normalized those of Cu, Mn and Zn in 
brain.  
Brain TBARS levels and TNFα and antioxidant enzymes expression  
Brain tissue levels of TBARS, measured as the lipid peroxidation end product 
malondialdehyde (MDA), were significantly higher (p < 0.001) in the Al group than in control 
mice. Brain levels of TBARS in the Al+Si and Al+beer groups were significantly lower (p < 
0.001) than those of the Al one (Fig. 1). 
The relative TNFα expression of the Al group significantly increased vs. control (p <0.001).   
This expression was significantly reduced in the Al+Si and Al+beer groups vs. their Al 
counterparts and non-differing (p >0.05) from that of control animals. (Fig. 1). 
The expression of MnSOD, CuZn-SOD and GPX enzymes was significantly lower (p<0.001) 
and GPX higher (p <0.001) in the Al group vs. control mice. Enzyme expressions ere 
normalized in the brains of the Al+Si and Al+beer, as their values did not differ from those of 
the control group (p>0.05) (Fig. 1). 
Metal levels, TBARS and gene expression relationships 
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Table 2 shows the non-parametric correlations between mineral and TBARS levels and the 
TNFα and antioxidant enzymes expression. Al correlated negatively and significantly with Cu 
(p <0.01), Mn and Fe (both p <0.05) and Zn (p <0.001) but positively with Si (p <0.001). Cu 
was positively correlated with Fe (p <0.01), Mg (p <0.001), Mn (p <0.01), while Fe positive 
and significantly correlated with Mn (p <0.001) and Zn (p <0.01). Zn showed positive 
correlation (p <0.001) with Mg levels. TBARS levels and TNFα expression were positively 
correlated with Al (both p <0.001) and Si (p <0.05 and p <0.01, respectively). Cu (p <0.01) 
and Zn (p <0.05) negatively correlated with TBARS and TNFα (both p <0.001). 
CAT gene expression showed significant positive correlations with Cu (p <0.001), Fe (p 
<0.05), Mg (p <0.05), Mn (p <0.05) and Zn (p<0.001), while CuZn-SOD gene expression 
with Cu (p <0.01) and Zn (p <0.001). Both CAT and CuZn-SOD expressions negatively 
correlated with Al (p <0.001) and Si (p<0.001) whereas GPx expression negatively with Cu (p 
<0.01), Fe (p <0.01), Mn (p <0.05) and Zn (p <0.01) but positively with Al (p <0.001) and Si 
(p <0.001). 
PCA results 
PCA was conducted to ascertain possible relationships between mineral and TBARS contents 
and TNFα and antioxidant enzymes expressions. Ten different variables were evaluated (Zn, 
Cu, Mn, Si and Al, CuZnSOD, Catalase, GPx, TNFα and TBARs). PCA created two 
components which explained the 71.2% of the total variance in the data set (Fig. 2a). First 
component (PC-1) accounted for 59.48% of the variance. It strongly and positively correlated 
with GPx, TNF-alpha, Al, and TBARs. Their values indicated in Table 3 were close to 1. Si 
was found relatively close to them with a 0.532 of PC-1. On the other hand, there were CAT 
and CuZn-SOD, with values close to -1, located on the left side of the plot (Fig. 2a), which 
correlated negatively with the previous ones. Second component (PC-2) explained 11.73% of 
the total variance. It positively correlated with Zn and Cu, both appearing negatively 
correlated also with PC-1 (Fig. 2a). Mn was in the middle of the two components, with a 
positive value of PC-2 but negative of PC-1.  
The PCA connected the pro-oxidant markers with Al content, and to a lesser extent 
with Si. On the contrary, Zn and Cu were closer to antioxidants enzymes. The PCA scatter 
plot (Fig. 2b) indicates the position of the studied groups (control, Al, Al+Si, Al+beer) in a 
graph compiled with two components (PC-1 and PC-2). It showed how the Al group was 
located on the positive part of PC-1 and close to 0 of PC-2. Control group appeared 
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oppositely in the negative part of both PC-1 and PC-2. Finally Al + Si and Al + beer were 
both located in the negative part of PC-1 as control group, but with more positive values of 
PC-2 than that group. 
 
Discussion 
Present results clearly show that Al administration induced changes in mineral contents and 
the in the inflammatory and oxidant/antioxidant status of brain. These negative effects were 
significantly reversed by the conjoint administration of Al with silicic acid or beer. 
There has been growing interest in the role of metal ions (especially Zn, Cu and Fe) in 
neurobiological processes. They participate in many essential activities, and their deficiencies 
can be lethal. Loss of Fe, Cu and Zn can lead to neurological disease, but conversely their 
accumulation or abnormal interactions with proteins, lipids or nucleic acids can also 
contribute to neurological disease [24]. Chronic exposure to Al induced reduction of Cu, Mn 
and Zn levels in the mouse brain. Yang et al.,[4] found that Fe, Zn, Mn, and Cu 
concentrations decreased in rat serum after Al administration, possibly because Al load 
caused liver uptake increase of those minerals. Thus, it can be speculated that the Cu, Mg and 
Zn decrease observed in brain following the Al administration could be a consequence of the 
lower plasma content of these metals. Others authors have suggested that also Al and some 
metals (i.g. Fe) compete for a common mechanism of gastrointestinal absorption [25, 26]; 
explaining, at least in part, the lower brain levels observed. In contrast, the level of Si 
increased in Al treated animals. Si has been suggested to interact with Al through the 
formation of non-toxic aluminosilicates that decrease free Al concentrations [11]. Formation 
of aluminosilicate prevents Al intestinal absorption, and thus prevents chronic aluminum 
accumulation that may cause or enhance neurodegeneration in the brain [27].  
The conjoint administration of Al and silicic acid or beer, partially blocked the 
negative effects of Al in the metal dysbalance observed. Si and silicic acid may decrease Al 
bioavailability by blocking gastrointestinal tract uptake [11] and reabsorption [12]; thus, 
explaining the lower amounts of Al in Al+Si and Al+beer brain mice and the normalization of 
metals affected by Al intoxication. Brain Si concentrations in Al+Si and Al+beer mice were 
higher than those of the animals in the basal group probably due to a number of different 
causes. There is evidence that Al is able to produce free radicals that cause lipid peroxidation, 
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thereby damaging neuronal membranes and increasing blood–brain barrier permeability [28], 
allowing more Si to enter the brain tissue. The negative correlations between Al with Cu, Fe, 
Mn, and Zn but positive with Si strengths the potential mechanisms already discussed.  
Changes observed in TBARS, TNF and enzymes expression in Al group suggests a 
toxic and pro-oxidant effect due to the metal dysbalance induced by Al intoxication. Cu is 
also required for mitochondrial respiration, neurotransmitter biosynthesis and as a cofactor for 
antioxidant enzymes [29]. Some other findings suggest that AD could be the result of 
diminished availability of Cu in neurons. Cu acts at different levels: it participates in AβPP 
processing into non-amyloidogenic derivatives although its deficiency reduces Aβ 
degradation [30]. Cu deficiency may also influence the activity of Cu-binding proteins in AD. 
For example, activity of the Cu-dependent proteins, Cu/Zn superoxide dismutase (SOD) [31] 
and cytochrome C oxidase [32] has been reported to be reduced in AD patients when 
compared to controls. This suggests that altered Cu homeostasis exists in AD and that such 
alteration can lead redox disequilibrium by altering the functioning of important enzymes like 
Cu,Zn-SOD and ceruloplasmin [33]. Therefore, the decrease in Cu levels caused by Al could 
explain, in part, the decreased expression of Cu,Zn-SOD observed in rats treated with Al [4]. 
Results obtained by Bayer et al.[34] and Phinney et al.[35] show that both dietary and genetic 
manipulations, that increase brain Cu levels, improved amyloid pathology in two strains of 
AβPP transgenic mice. Silicon administration, as organic silicon or beer, restores brain levels 
of Cu and regulates expression of Cu,Zn-SOD. The hypothesis that silicon may be beneficial 
by altering the absorption and utilization of other mineral elements involved in bone 
metabolism, immune or inflammatory response, or cognitive function cannot be discounted 
[36]. Silicon, especially in supra nutritional amounts, has been reported to facilitate the 
absorption, retention, and/or utilization of copper [37] and magnesium [38].These data 
indicate that some of the metabolic effects attributed to silicon may be manifested through a 
silicon-facilitated increase in copper utilization [39]. The high positive correlation obtained 
between brain Cu levels and gene expression of Cu,Zn-SOD, as well as the negative 
correlation of Al levels with this enzyme support previous comments. 
Zn nutritional deficiency is common in advanced age, and a recent report indicated 
that Zn deficiency in AβPP transgenic mice increased the volume of amyloid plaques [39]. 
Zinc acts as a neuromodulator at excitatory synapses and has a considerable role in the stress 
response and in the functionality of zinc-dependent enzymes, contributing to maintaining 
brain compensatory capacity [40]. The data obtained by Cuajungco and Fagét, [41] suggest a 
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protective role for Zn(2+) in AD, where plaques form as the result of a more robust Zn(2+) 
antioxidant response to the underlying oxidative attack. In particular, the mechanisms that 
modulate the free zinc pool are pivotal for safeguarding brain health and performance. 
Alterations in zinc metabolism and homeostasis have been reported in Parkinson’s and 
Alzheimer’s disease as well as in transient forebrain ischemia, seizures and traumatic brain 
injury, but little is known regarding aged brain [42].  
Present results suggest that Al poisoning causes a significant decrease in the brain 
levels of zinc; the effect being reversed when Si was administered. Therefore, the Si could 
somehow mitigate the damage induced by Al, restoring Zn homeostasis in the brain. These 
results are correlated with increased expression of Cu/Zn SOD observed after administration 
of the beer or silicon aluminum intoxicated rats [5]. As for Cu, it found significant positive 
correlations between brain Zn levels and gene expression of Cu,Zn-SOD. 
Fe is required to support the brain’s high respiratory rate as well as for myelination, 
gene expression and neurotransmitters synthesis [43]. According to Yang et al. [4] Al easily 
occupies the binding sites of Fe, decreasing the interactions between Fe
2+
 and iron 
transporters. This increase in free Fe
2+
 level and thus, the production of a large amount of 
active oxygen free radicals, could result in cell membrane lipid peroxidation, accelerated cell 
apoptosis and necrosis, and mitochondrial function damage that clearly link with the 
impairment of the antioxidant and inflammation status observed in Al mice. Contini et al. [44] 
observed that the malregulation of intestinal Fe absorption in Al exposure inducing decrease 
of serum Fe concentration could be the result of the increased lipid peroxidation (TBARS) 
observed in this tissue. Mucosal TBARS were increased by Al exposure (+26%). In the 
present study, TBARS increased by Al exposure 2.15 fold (+46%) vs. control.  
As the brain Al levels are diminished after Al+Si or Al+beer administration, it can be 
suggested that the interaction Al-Fe
2+
 and thus, the active oxygen free radicals, may be 
reduced, explaining the improvement in the inflammation and antioxidant status observed. In 
fact, the concentration of brain Fe was significantly and positively correlated with gene 
expression of catalase and negatively with the expression of GPx and TNFα.  
Although direct interaction between Mn and Aβ has not been reported yet, recent 
reports have highlighted the impact of loss of MnSOD or SOD2 on AD pathology in APP 
transgenic AD models [45]. MnSOD is found exclusively in mitochondria and heterozygotic 
genetic ablation of MnSOD leads to increased oxidative stress [46]. This raises the hypothesis 
13 
 
that Mn deficiency might increase the risk for AD and other brain degenerative diseases. Our 
results showed a significant reduction in Mn levels in the brains of mice intoxicated with Al. 
Also the MnSOD was highly decresed, suggesting that brain mitochondria metabolism was 
highly affected in Al group. The administration of Si as silicic acid or beer achieved to 
reestablish both levels Mn and values MnSOD in brain, suggesting that silicic acid and beer 
improved the antioxidant defense of the brain through ameliorating Mn-SOD expression. 
Very recently our group has observed that Si protected neuroblastoma cells from H2O2 
aggression [8, 9]. Moreover, Si increased liver Si content and improved the liver antioxidant 
status in cholesterol fed-aged rats [10]. 
As commented Al intoxication, directly or by inducing metal dysbalance, provoked 
oxidative stress and dysregulation in the antioxidant enzymes expression. Such alterations 
were blocked and reversed by the conjoint administration of Al+Si or Al+beer. This outcome 
was easily observed in the PCA scatter plot which located Al+Si and Al+beer groups close to 
control mice, suggesting a reversion of Al intoxication effects. 
Conclusion  
Chronic Al leads to metal dysbalance in brain inducing brain inflammatory and pro-oxidant 
status impairment that in turn could contribute to neurological disease progression. Present 
study is the first showing that Si inclusion in the diet, in the form of silicic acid or beer, helps 
to recover the depleted levels of Cu, Fe, Mn, and Zn in the brain negatively affected by Al 
administration, allowing to improve oxidation and inflammatory markers and the antioxidant 
status in brain.  
 
Acknowledgements 
This study was supported by the Asociación de Cerveceros Españoles, proyect XF20 and by 
the project AGL2011-29644-C02-02 and AGL2014-53207-C2-2-R (Ministerio de Economía 
y Competitividad). We also acknowledge the pre-doctoral fellowship granted to Alba 
Garcimartín by BES-2012-054752 (FPI). 
 
References 
14 
 
1. Liu G, Huang W, Moir RD, Vanderburg CR, Lai B, Peng Z, Tanzi RE, Rogers J, Huang X 
(2006) Metal exposure and Alzheimer’s pathogenesis. J Struct Biol 155, 45–51. 
2. Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaset J (2014) The neurotoxicity 
of iron, copper and manganese in Parkinson’s and Wilson’s diseases. J Trace Elem Med Biol 
31, 193-203. 
3. Exley C (2005) The aluminium–amyloid cascade hypothesis and Alzheimer’s disease. 
Subcell Biochem 38, 225–234. 
4. Yang Y, Wang H, Guo Y, Lei W, Wang J, Hu X, Yang J, He Q (2016) Metal Ion 
Imbalance-Related Oxidative Stress Is Involved in the Mechanisms of Liver Injury in a Rat 
Model of Chronic Aluminum Exposure. Biol Trace Elem Res.  [Epub ahead of print] 
5. Gonzalez-Muñoz MJ, Meseguer I, Sanchez-Reus MI, Schultz A, Olivero R, Benedí J, 
Sánchez-Muniz FJ (2008) Beer consumption reduces cerebral oxidation caused by aluminum 
toxicity by normalizing gene expression of tumor necrotic factor alpha and several antioxidant 
enzymes. Food Chem Toxicol 46(3), 1111-1118. 
6. Xie CX, Mattson MP, Lovell MA, Yoke R (1996) Intraneuronal aluminum potentiates iron-
induced oxidative stress in cultured rat hippocampal neurons. Brain Res 16, 743(1-2), 271-7. 
7. Chumlea WC (2007). Editorial: silica, a mineral of unknown but emerging health 
importance. J Nutr Health Aging 11, 93. 
8. Garcimartín A, Merino JJ, González MP, Sánchez-Reus MI, Sánchez-Muniz FJ, Bastida S, 
Benedí J (2014) Organic silicon protects human neuroblastoma SH-SY5Y cells against 
hydrogen peroxide effects. BMC Complement Altern Med 14: 384. 
9. Garcimartín A, Merino JJ, Santos-López JA, López-Oliva ME, González MP, Sánchez-
Muniz FJ, Benedí J. (2015) Silicon as neuroprotector or neurotoxic in the human 
neuroblastoma SH-SY5Y cell line. Chemosphere 135: 217-224. 
10. Santos-López JA, Garcimartín A, Merino P, López-Oliva ME, Bastida S, Benedí J, 
Sánchez-Muniz FJ. (2016). Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork 
on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets. PLoS 
One 11 (1): e0147469. doi: 10.1371. 
15 
 
11. Gillette-Guyonnet S, Andrieu S, Vellas B (2007) The potential influence of silica 
presentin drinking water on Alzheimer’s disease and associated disorders. J Nutr Health 
Aging 11, 119–124. 
12. Bellia JP, Birchall JD, Roberts NB (1996) The role of silicic acid in the renal excretion of 
aluminium. Annal Clin Lab Sci 26(3), 227-233. 
13. Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminium, arsenic and lithium: 
essentiality and human health implications. J Nutr Health Aging 6, 154–162. 
14. Sripanyakorn S, Jugdaohsingh R, Elliott H, Walker C, Mehta P, Shoukru S (2004) The 
silicon content of beer and its bioavailability in healthy volunteers. Brit J Nutr 91, 403–409. 
15. González Muñoz MJ, Peña A, Meseguer I (2007) Role of beer as a possible protective 
factor in preventing Alzheimer’s disease. Food Chem Toxicol 46, 49-56.  
16. Pandya JD, Dave KR, Katyare SS (2004) Effect of long-term aluminum feeding on 
lipid/phospholipid profiles of rat brain myelin. Lipids Health Dis 3, 13. 
hwww.lipidworld.com/render/render.aspi. 
17. Peña A, Meseguer I, González MJ (2006) Posible efecto protector de la cerveza sobre la 
toxicidad del aluminio. Rev. Toxicol 22 (Suppl. 1).http://tox.umh.es/aetox/index.htm. 
18. Granero S, Vicente M, Aguilar V, Martínez-Para MC, Domingo JL (2004) Effects of beer 
as a source of dietary silicon on aluminium absorption and retention in mice. Trace Elem. 
Electroly 21, 28–32. 
19. EURACHEM Guide (1998) The Fitness for Purpose of Analytical Methods A Laboratory 
Guide to Method Validation and Related Topics. First Internet Version. 
20. Bermejo P, Gómez-Serranillos P, Santos J, Pastor E, Gil P, Martín-Aragón S (1997) 
Determination of malonaldehyde in Alzheimer's disease: a comparative study of high-
performance liquid chromatography and thiobarbituric acid test. Gerontology 43(4), 218-22. 
21. Bradford, M M (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 
72, 248-54. 
16 
 
22. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1), 156-9. 
23. Hollander M, Wolfe DA (1973) Nonparametric Statistical Method. Wiley, New York.  
24. Barnham KJ, Bush AI (2008) Metals in Alzheimer's and Parkinson's diseases. Curr Opin 
Chem Biol 2(2), 222-8. 
25. Walton JR (2012) Evidence that total dietary aluminum ingestion is a major risk factor for 
Alzheimer's disease. Curr  Inorg Chem 2, 19-39. 
26. Di Paolo C, Reverte I, Colomina MT, Domingo JL, Gómez M (2014) Chronic exposure to 
aluminum and melatonin through the diet: neurobehavioral effects in a transgenic mouse 
model of Alzheimer disease. Food Chem Toxicol 69, 320-329. 
27. Domingo JL, Gómez M, Colomina MT (2011) Oral silicon supplementation: an effective 
therapy preventing oral aluminum absorption and retention in mammals. Nutr Rev 69, 41–51. 
28. Srivastava RA, Jain JC (2002) Scavenger receptor class B type I expression and elemental 
analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain. J Neurol 
Sci 15, 196(1-2), 45-52. 
29. Peña MM, Lee J, Thiele DJ (1999) A delicate balance: homeostatic control of copper 
uptake and distribution. J Nutr 129, 1251–1260. 
30. Cater MA, McInnes KT, Li QX, Volitakis I, La FS, Mercer JF, Bush AI (2008) 
Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms. 
Biochem J 412, 141–152. 
31. Boll MC, Alcaraz-Zubeldia M, Montes S, Rios C (2008). Free copper, ferroxidase and 
SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile 
in four neurodegenerative diseases. Neurochem Res 33, 1717–1723. 
32. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present 
in brain of Alzheimer disease patients. Neurobiol Aging 21, 455–462. 
33. Rivera-Mancía S, Pérez-Neri I, Ríos C, Tristán-López L, Rivera-Espinosa L, Montes S 
(2010) The transition metals copper and iron in neurodegenerative diseases. Chem Biol 
Interact 186, 184–199. 
17 
 
34. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepests R, Eckert A, Schussel 
K, Eikenberg O, Sturchler-Pierrat C, et al. (2003) Dietary Cu stabilizes brain superoxide 
dismutase 1 activity and reduces amyloid A{beta} production in APP23 transgenic mice. 
Proc Natl Acad Sci USA 100, 14187-14192. 
35. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang 
J, Sekoulidis J, Coomaraswamy J et al. (2003) In vivo reduction of amyloid-{beta} by a 
mutant copper transporter. Proc Natl Acad Sci USA 100, 14193-14198. 
36. Nielsen F (2014) Update on the possible nutritional importance of silicon.  J Med Biol 
Traza Elem 28, 379–382. 
37. Emerick R, Kayongo-Male H (1990) Silicon facilitation of copper utilization in the rat. J 
Nutr Biochem 1, 487–92. 
38. Kikunaga S, Kitano T, Kikukawa T, Takahashi M (1991) Effects of fluoride and silicon 
on distribution of minerals in the magnesium-deficient rat. Maguneshumu 10, 181–91. 
39. Sparks DL, Friedland R, Petanceska S, Schreurs BG, Shi J, Perry G, Smith MA, Sharma 
A, Derosa S, Ziolkowski C et al. (2006) Trace copper levels in the drinking water, but not 
zinc or aluminum influence CNS Alzheimer-like pathology. J Nutr Health Aging 10, 247-254. 
40. Takeda A, Minami A, Takefuta S, Tochigi M, Oku N (2001) Zinc homeostasis in the 
brain of adult rats fed zinc-deficient diet. J Neurosci Res 63(5), 447-52. 
41. Cuajungco M, Fagét KY (2003). Zinc takes the center stage: its paradoxical role in 
Alzheimer’s disease. Brain Res Brain Res Rev 41, 44–56. 
42. Mocchegiani E, Bertoni-Freddari C, Marcellini F, Malavolta M (2005) Brain, aging and 
neurodegeneration: role of zinc ion availability. Prog Neurobiol 75(6), 367-90. 
43. Beard JL, Connor JR (2003) Iron status and neural functioning. Annu Rev Nutr 23, 41–58. 
44. Contini MC, Ferri A, Bernal CA, Carnovale CE (2007)  Study of iron homeostasis 
following partial hepatectomy in rats with chronic aluminum intoxication. Biol Trace Elem 
Res 115(1), 31-45. 
18 
 
45. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT (2009) Reduction of 
oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase 
overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 23(8), 2459-66. 
46. Candas D, Li JJ (2014) MnSOD in oxidative stress response-potential regulation via 
mitochondrial protein influx. Antioxid Redox Signal, 20(10), 1599-617. 
19 
 
 
